Iovance Biotherapeutics Inc. buy CapIPO39
Start price
25.01.25
/
50%
€6.00
Target price
25.02.25
-
Performance (%)
-15.08%
End price
26.02.25
€5.09
Summary
This prediction ended on 26.02.25 with a price of €5.09. The price of Iovance Biotherapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.08%. CapIPO39 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 8.217% | 8.217% | 3.201% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
Comments by CapIPO39 for this prediction
In the thread Trading Lion Biotechnologies Inc
Die von CapIPO39 gewählte maximale Laufzeit wurde überschritten